Modern Practice Podcast

What does transformation look like in the post-pandemic era? – Part 2

Drastic forces unleashed by COVID-19 have transformed everything, including health care. Clinical care delivery has changed. Health policies have changed. Regulation and payment have changed. Whether or not these changes will last is up in the air as the pandemic enters a second year. On this episode, part two of a series, Modern Practice brings back an expert who will look at what has happened and address questions and concerns about what will happen.
 
Guest speaker:Celina BurnsPrincipalFinancial Performance SolutionsVizient
 
Moderator:Tomas Villanueva, DO, MBA, FACPE, SFHMAssociate Vice PresidentClinical ResourcesVizient
 
Show Notes:[00:23] Acquisition, compensation and productivity[02:27] Hospital-physician engagement[03:59] Care access in the future and Walmart “health hubs”[05:55] Health insurance trends and the payor role[08:38] Head winds in the work force[10:18] Redesign and Social Determinants of Health
 
Links | Resources:
Practice and Policy Reset Post-COVID-19 Click here
 
Subscribe Today!
Apple Podcasts
Spotify
Android
Google Podcasts
Stitcher
RSS Feed
 

What does transformation look like in the post-pandemic era? – Part 1

The COVID pandemic has transformed all of health care, from the way patients access care to the way clinicians conduct it. In this episode, the first of a two-part series, we will examine how health policies and clinical practice have taken on never-before-seen aspects and where these changes might lead in the future.
 
Guest speaker:Celina BurnsPrincipalFinancial Performance SolutionsVizient
 
Moderator:Tomas Villanueva, DO, MBA, FACPE, SFHMAssociate Vice PresidentClinical ResourcesVizient
 
Show Notes:[00:54] Care moving toward virtual/ambulatory and lower-cost sites[01:53] Changes in financial landscape[02:48] Bringing secrets to light[04:33] Consolidation and mergers; move to regionalized care[05:27] Relieving the pressure[08:06] Value-based payments
 
Links | Resources:
Practice and Policy Reset Post-COVID-19 Click here
 
Subscribe Today!
Apple Podcasts
Spotify
Android
Google Podcasts
Stitcher
RSS Feed
 

Monoclonal antibody therapy for COVID-19 – Part 3

In Part 3 of this series on monoclonal antibody therapies for COVID-19, our expert panel continues their discussion on concerns about the efficacy and distribution of these treatment options. They respond to the FDA’s recent Emergency Use Authorization (EUA) for monoclonal antibodies.
 
Guest speakers:Azra Behlim, PharmD, MBASenior DirectorPharmacy Sourcing and Program Services Vizient
Stacy Lauderdale, PharmDSenior DirectorDrug InformationVizient
Steve Rudner, PharmD, MSDirectorPharmacy Network ContractingVizient
 
Moderator:Tomas Villanueva, DO, MBA, FACPE, SFHMAssociate Vice PresidentClinical ResourcesVizient
 
Show Notes:[00:37] Identifying the right patients – best practices[03:10] The access challenge[05:54] Plenty of availability[06:10] COVID vaccination and use of monoclonal antibody therapy[06:37] Post-infusion management
 
Links | Resources:
Press release and information from FDA Click here
Information from FDA on EUA for monoclonal antibody therapy Click here
ASPR’s portfolio of COVID-19 medical countermeasures (HHS site) Click here
[ For more information, contact: ASPRstakeholder@HHS.gov ]
JAMA article: “An EUA for Bamlanivimab—A Monoclonal Antiboey for COVID-19” (Dec. 11, 2020) Click here
 
Subscribe Today!
Apple Podcasts
Spotify
Android
Google Podcasts
Stitcher
RSS Feed
 

Monoclonal antibody therapy for COVID-19 – Part 2

Last November, the FDA released an Emergency Use Authorization (EUA) for the use of monoclonal antibody therapy for adult and pediatric patients with mild to moderate COVID-19. Currently, there is some confusion about the availability and access issues to these treatment options.
 
In this episode, part two of a three-part series, we will address questions and concerns about the distribution and availability of these therapies.
 
Guest speakers:Azra Behlim, PharmD, MBASenior DirectorPharmacy Sourcing and Program Services Vizient
 
Steve Rudner, PharmD, MSDirectorPharmacy Network ContractingVizient
 
Moderator:Tomas Villanueva, DO, MBA, FACPE, SFHMAssociate Vice PresidentClinical ResourcesVizient
 
Show Notes:[02:05] Access to the monoclonal antibody therapies[03:51] No lack of supply[05:07] Infusion options[09:59] Misconceptions and challenges around distribution[11:40] Every idea worth exploring
 
Links | Resources:
Press release and information from FDA Click here
Information from FDA on EUA for monoclonal antibody therapy Click here
ASPR’s portfolio of COVID-19 medical countermeasures (HHS site) Click here
[ For more information, contact: ASPRstakeholder@HHS.gov ]
JAMA article: “An EUA for Bamlanivimab—A Monoclonal Antiboey for COVID-19” (Dec. 11, 2020) Click here
 
Subscribe Today!
Apple Podcasts
Spotify
Android
Google Podcasts
Stitcher
RSS Feed
 

Monoclonal antibody therapy for COVID-19 – Part 1

COVID-19 vaccines have dominated the headlines. Not garnering the same attention, but just as important, is last November’s US Food and Drug Administration Emergency Use Authorization (EUA) allowing monoclonal antibody therapy for adult and pediatric patients with mild to moderate COVID-19.
 
This episode, beginning a three-part series on this treatment option, will address questions and concerns about the administration of monoclonal antibody therapy.
 
Guest speaker:
Stacy Lauderdale, PharmD
Senior Director
Drug Information
Vizient
 
Moderator:
Tomas Villanueva, DO, MBA, FACPE, SFHM
Associate Vice President
Clinical Resources
Vizient
 
Show Notes:
[01:05] Science behind the treatment
[02:09] Evidence is compelling but hypothesis-generating
[03:43] Choosing an option
[04:37] Role of COVID testing
[04:52] Inclusion and exclusion factors
[06:17] Risk of anaphylaxis
[06:54] Social determinants for treatment
[07:44] Patient risk factors
 
Links | Resources:
Press release and information from FDA Click here
Information from FDA on EUA for monoclonal antibody therapy Click here
ASPR’s portfolio of COVID-19 medical countermeasures (HHS site) Click here
[ For more information, contact: ASPRstakeholder@HHS.gov ]
JAMA article: “An EUA for Bamlanivimab—A Monoclonal Antiboey for COVID-19” (Dec. 11, 2020) Click here
 
Subscribe Today!
Apple Podcasts
Spotify
Android
Google Podcasts
Stitcher
RSS Feed
 

Advancing team culture: workforce effectiveness during COVID-19 and beyond – Part 3

In this third and final episode of our series on building a team culture, we examine the role of scope of practice, training and fostering a psychologically safe environment to improve and sustain workforce capability.
 
Guest speakers:
Robert Dean, DO, MBA
Senior Vice President
Performance Management
Vizient
 
Katie Davis, RN, MS-HSM
Clinical Workforce Solutions Intelligence Director
Vizient
 
Moderator:
Tomas Villanueva, DO, MBA, FACPE, SFHM
Associate Vice President
Clinical Resources
Vizient
 
Show Notes:
[00:20] Scope of practice and team-based care
[05:59] Core competencies
[08:44] Story from Northwestern Memorial Hospital
[09:38] A new timeline
[09:56] Attributes of a team-based culture
[10:51] The role of virtual health
[11:48] Story from Vidant Health
 
Links | Resources:
Vizient playbook: Advancing team culture for workforce effectiveness Click here
“Disruptive and Toxic Behaviors in Healthcare (Holloway, Kusy) Click here
Leading Frontline COVID-19 Teams: Research-Informed Strategies (Kerrisey, Singer—NEJM Catalyst, September 2020) Click here
What Healthcare Workers Need from Leaders in COVID-19 Crisis (Ratanjee, Foy – Gallup, April 2020) Click here
Diversity Still Matters (Dolan, Hunt, Prince, Sancier-Sultan—McKinsey & Company, May 2020) Click here
“Implementing Optimal Team-Based Care to Reduce Clinician Burnout” (National Academy of Medicine discussion paper – September 17, 2018) Click here
“Association Between Provider Engagement, Staff Engagement, and Culture of Safety” (Journal of Healthcare Quality, July/Aug 2020) Click here
Toxic Workplace!: Managing Toxic Personalities and Their Systems of Power (Kusy, Holloway). Book ordering information: Click here
 
Subscribe Today!
Apple Podcasts
Spotify
Android
Google Podcasts
Stitcher
RSS Feed
 

Advancing team culture: workforce effectiveness during COVID-19 and beyond – Part 2

Despite the challenges COVID-19 has posed to health care teams, these teams have proved resilient and innovative during the crisis. However, sustaining and building on the improvements these teams have made means creating a lasting culture of teamwork. In part two of this three-part series, we consider the role of communication and conflict management in establishing this culture.
 
Guest speakers:
Robert Dean, DO, MBA
Senior Vice President
Performance Management
Vizient
 
Katie Davis, RN, MS-HSM
Clinical Workforce Solutions Intelligence Director
Vizient
 
Moderator:
Tomas Villanueva, DO, MBA, FACPE, SFHM
Associate Vice President
Clinical Resources
Vizient
 
Show Notes:
[00:17] Nurturing the continued development of effective teams
[01:42] Importance of two-way communication to innovation
[02:53] Dealing with disruptive team members
[09:43] Building the foundation of a team-based culture: leadership
 
Links | Resources:
Vizient playbook: Advancing team culture for workforce effectiveness Click here
“Disruptive and Toxic Behaviors in Healthcare (Holloway, Kusy) Click here
Leading Frontline COVID-19 Teams: Research-Informed Strategies (Kerrisey, Singer—NEJM Catalyst, September 2020) Click here
What Healthcare Workers Need from Leaders in COVID-19 Crisis (Ratanjee, Foy – Gallup, April 2020) Click here
Diversity Still Matters (Dolan, Hunt, Prince, Sancier-Sultan—McKinsey & Company, May 2020) Click here
“Implementing Optimal Team-Based Care to Reduce Clinician Burnout” (National Academy of Medicine discussion paper – September 17, 2018) Click here
“Association Between Provider Engagement, Staff Engagement, and Culture of Safety” (Journal of Healthcare Quality, July/Aug 2020) Click here
Toxic Workplace!: Managing Toxic Personalities and Their Systems of Power (Kusy, Holloway). Book ordering information: Click here
 
Subscribe Today!
Apple Podcasts
Spotify
Android
Google Podcasts
Stitcher
RSS Feed
 

Advancing team culture: workforce effectiveness during COVID-19 and beyond – Part 1

During the COVID-19 pandemic, the health care workforce has shown resiliency and agility in the face of unprecedented challenges. Yet, sustaining and improving on the advances made in the past year means building a culture of teamwork. In part one of our three-part series on workforce effectiveness, we examine what has hindered effective teamwork in the past, the challenges posed by COVID and how teams can sustain the efforts they have made and improve on those efforts in the future.
 
Guest speakers:
Robert Dean, DO, MBA
Senior Vice President
Performance Management
Vizient
 
Katie Davis, RN, MS-HSM
Clinical Workforce Solutions Intelligence Director
Vizient
 
Moderator:
Tomas Villanueva, DO, MBA, FACPE, SFHM
Associate Vice President
Clinical Resources
Vizient
 
Show Notes:
[01:30] Inhibitions to team-based care
[04:07] Effect of the pandemic
[06:16] The team defined
[07:29] Characteristics of effective team-based care
[10:27] Benefits of team-based care
[11:34] Approaches that need to continue
 
Links | Resources:
Vizient playbook: Advancing team culture for workforce effectiveness Click here
“Disruptive and Toxic Behaviors in Healthcare (Holloway, Kusy) Click here
Leading Frontline COVID-19 Teams: Research-Informed Strategies (Kerrisey, Singer—NEJM Catalyst, September 2020) Click here
What Healthcare Workers Need from Leaders in COVID-19 Crisis (Ratanjee, Foy – Gallup, April 2020) Click here
Diversity Still Matters (Dolan, Hunt, Prince, Sancier-Sultan—McKinsey & Company, May 2020) Click here
“Implementing Optimal Team-Based Care to Reduce Clinician Burnout” (National Academy of Medicine discussion paper – September 17, 2018) Click here
“Association Between Provider Engagement, Staff Engagement, and Culture of Safety” (Journal of Healthcare Quality, July/Aug 2020) Click here
Toxic Workplace!: Managing Toxic Personalities and Their Systems of Power (Kusy, Holloway). Book ordering information: Click here
 
Subscribe Today!
Apple Podcasts
Spotify
Android
Google Podcasts
Stitcher
RSS Feed
 

Update on MACRA Rule 2021 – Part 2

This is Part 2 of our discussion on the latest MACRA Rule for 2021. Leading experts from Sg2 discuss the issues that affect reimbursement for medical and clinical practices, including Advanced APMs and what they could mean for you.
 
Guest speakers:
Valinda Rutledge, MBA, MSN
Fellow
Sg2
 
Madeleine McDowell, MD
Principal, Intelligence
Sg2
 
Moderator:
Tomas Villanueva, DO, MBA, FACPE, SFHM
Associate Vice President
Clinical Resources
Vizient
 
Show Notes
[00:44] Advanced Alternative Payment Models (aAPMs)—descriptions, developments
[06:44] Outpatient Prospective Payment System (OPPS)—changes
[08:16] Accountable Care Organizations (ACOs)—changes, options
[11:19] Alternative Payment Model Performance Pathway (APP)—measures, options
[12:22] Ramifications of elimination of Inpatient Only (IPO) list
[14:06] Medicare Physician Fee Schedule—developments
[15:44] Three themes from CMS continuing
 
Links | Resources:
Program handout from December 9, 2020 webcast: Click here
Link to December 9 webcast: Click here
CMS website on MACRA and QPP Click here
 
Subscribe Today!
Apple Podcasts
Spotify
Android
Google Podcasts
Stitcher
RSS Feed
 

Update on MACRA Rule 2021 – Part 1

For physician and clinician leaders, this episode provides the latest information on regulatory activities, including the final MACRA Rule for 2021, that will impact reimbursement. We will discuss changes to the Quality Payment Program, E&M Codes and the Merit-based Incentive Payment System (MIPS), along with the MIPS Value Pathways (MVPs). This is information crucial to physicians and clinicians.
 
Guest speakers:
Valinda Rutledge, MBA, MSN
Fellow
Sg2
 
Madeleine McDowell, MD
Principal, Intelligence
Sg2
 
Moderator:
Tomas Villanueva, DO, MBA, FACPE, SFHM
Associate Vice President
Clinical Resources
Vizient
 
Show Notes:
[01:58] E&M Code changes: background, rationale, details—after years of development
[06:56] Virtual health changes
[10:38] Expanding scope of practice and team-based care
[12:21] The MACRA Rule—details and ramifications
[16:16] Uncontrollable circumstances – applying for adjustments
[16:45] Merit-based Incentive Payment System (MIPS) update
[20:47] MIPS Value Pathways (MVPs)
 
Links | Resources:
Program handout from December 9, 2020 Vizient Medical Leadership Series webcast: Click here
Link to December 9 webcast: Click here
CMS website on MACRA and QPP Click here
 
Subscribe Today!
Apple Podcasts
Spotify
Android
Google Podcasts
Stitcher
RSS Feed